SLC5A2 and Hyperglycemia: Notably, the beneficial effects of SGLT2 inhibitors on vascular cell function and remodeling are observed in the presence and absence hyperglycemia, suggesting that SGLT2 inhibitors will be effective in treating vascular disease beyond the diabetic population.